Homeopathic treatment of complaints before menses

Validation of translated Bengali questionnaires assessing pre-menstrual syndrome & open observational trial to evaluate effectiveness of individualized homoeopathic treatment

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013414

Enrollment

112

Registered

2018-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Premenstrual syndrome (PMS)

Interventions

Intervention1: Indicated homoeopathic medicines in centesimal or fifty millesimal potencies: Indicated homoeopathic medicines in centesimal or fifty millesimal potencies, as decided appropriate to the

dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globules of poppy seed size (no. 10) shall be dissolved in 90 ml dis

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from PMS, diagnosed as per ICD-10 criteria 2. Persistence of symptoms for more than 3 months 3. Age: 18-45 years 4. Patients taking oral contraceptive pills (OCPs) will be advised to stop pills till it exhaust for the ongoing cycle, followed by re-assessment of symptoms in the next cycle enrolment 6. Patients under hormonal replacement therapy (HRT) to be included after a washout period of 3 months 7. Ability to read Bengali 8. Patients giving written consent to participate

Exclusion criteria

Exclusion criteria: 1. Patients underwent hysterectomy and/or bilateral oophorectomy 2. Primary or secondary amenorrhoea 3. Change in hormone status (introduction of an oestrogen and/or progestogen, amenorrhoea, pregnancy etc.) 4. Patients having history of breast or reproductive organ cancer 5. Unevaluated gynaecological abnormalities; e.g. unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases (PID) within one month, patients with suspicious adenomyosis, gross developmental defect or congenital abnormalities of the uterus etc. 6. Patients with psychiatric diseases 7. Cases suffering from uncontrolled systemic illness, life-threatening infections, or any vital organ failure 8. Patients insisting to use OCPs and HRT 9. Cases already undergoing homoeopathic treatment for any chronic disease 10. Substance abuse and/or dependence 11. Self-reported immune-compromised state

Design outcomes

Primary

Measure	Time frame
Translated Bengali versions of Premenstrual Tension Syndrome Observer Rating Scale â?? Revised (PMTS-OR), self-rated Premenstrual Tension Syndrome and Visual Analogue Scale (PMTS-VAS)Timepoint: Baseline and 6 months	—

Secondary

Measure	Time frame
Translated Bengali version of Shortened Premenstrual Assessment Form (SPAF)Timepoint: Baseline and 6 months	—

Countries

India

Contacts

Public ContactSubhranil Saha

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

drsubhranilsaha@hotmail.com9831063837

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026